Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 3, 2007, Pages

  Sullivan, Cherese N ^a   Raboin, Shannon J ^a   Gulley, Stephen ^a   Sinzobahamvya, Ntwenzi T ^a   Green, Gary M ^b   Reeve Jr , Joseph R ^c   Sayegh, Ayman I ^a  

^a TUSKEGEE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Camostat; Devazepide; Vagotomy

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CAMOSTAT MESILATE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; IMMUNOREACTIVITY; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; VAGOTOMY; VAGUS NERVE;

ANIMALS; AREA POSTREMA; CHOLECYSTOKININ; EATING; IMMUNOHISTOCHEMISTRY; MALE; MODELS, BIOLOGICAL; MYENTERIC PLEXUS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; SOLITARY NUCLEUS; VAGUS NERVE;

EID: 33847718700     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00490.2006     Document Type: Article

References (55)

1. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044: 127-131, 2005.
2. Altschuler SM, Escardo J, Lynn RB, Miselis RR. The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology 104: 502-509, 1993.
3. Baggio LL, Huang Q, Brown TJ, Drucker DJ. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127: 546-558, 2004.
4. Baggio LL, Huang Q, Brown TJ, Drucker DJ. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53: 2492-2500, 2004.
5. Berghorn KA, Bonnett JH, Hoffman GE. cFos immunoreactivity is enhanced with biotin amplification. J Histochem Cytochem 42: 1635-1642, 1994.
6. Berthoud HR. Anatomical demonstration of vagal input to nicotinamide acetamide dinucleotide phosphate diaphorase-positive (nitrergic) neurons in rat fundic stomach. J Comp Neurol 358: 428-439, 1995.
7. Berthoud HR, Blackshaw LA, Brookes SJ, Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 16 Suppl1: 28-33, 2004.
8. Berthoud HR, Jedrzejewska A, Powley TL. Simultaneous labeling of vagal innervation of the gut and afferent projections from the visceral forebrain with dil injected into the dorsal vagal complex in the rat. J Comp Neurol 301: 65-79, 1990.
9. Chi MM, Fan G, Fox EA. Increased short-term food satiation and sensitivity to cholecystokinin in neurotrophin-4 knock-in mice. Am J Physiol Regul Integr Comp Physiol 287: R1044-R1053, 2004.
10. Chi MM, Powley TL. c-Kit mutant mouse behavioral phenotype: altered meal patterns and CCK sensitivity but normal daily food intake and body weight. Am J Physiol Regul Integr Comp Physiol 285: R1170-R1183, 2003.
11. Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29: 261-265, 1989.
12. Fraser KA, Davison JS. Cholecystokinin-induced c-fos expression in the rat brain stem is influenced by vagal nerve integrity. Exp Physiol 77: 225-228, 1992.
13. Fuxe K, Agnati LF, Vanderhaeghen JJ, Tatemoto K, Andersson K, Eneroth P, Harfstrand A, Von Euler G, Toni R, Goldstein M. Cholecystokinin neuron systems and their interactions with the presynaptic features of the dopamine neuron systems A morphometric and neurochemical analysis involving studies on the action of cholecystokinin-8 and cholecystokinin-58. Ann NY Acad Sci 448: 231-254, 1985.
14. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
15. Goke B, Printz H, Koop I, Rausch U, Richter G, Arnold R, Adler G. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Pancreas 1: 509-515, 1986.
16. Gorelick FS. Pancreas cell physiology and pancreatitis cell biology. Summary of a symposium held at the joint meeting of the EPC and the IAP, Heidelberg 2002. Pancreatology 3: 207-208, 2003.
17. Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 51 Suppl 1: i2-i5, 2002.
18. Grundy D. Signalling the state of the digestive tract. Auton Neurosci 125: 76-80, 2006.
19. Gulley S, Covasa M, Ritter RC, Sayegh AI. Cholecystokinin1 receptors mediate the increase in Fos-like immunoreactivity in the rat myenteric plexus following intestinal oleate infusion. Physiol Behav 86: 128-135, 2005.
20. Gulley S, Raboin SJ, Henley SC, Chan WC, Sharma SK, Billups LH, Esdaile AR, Sullivan CN, Moran TH, Sayegh AI. Chemical sympathectomy attenuates myenteric but not dorsal vagal complex Fos-like immunoreactivity induced by cholecystokinin-8 in the rat. Brain Res 1064: 119-125, 2005.
21. Gulley S, Sharma SK, Mansour M, Sullivan CN, Moran TH, Sayegh AI. Strain differences in myenteric neuron number and CCK(1) receptor mRNA expression may account for differences in CCK-induced c-Fos activation. Brain Res 1058: 109-119, 2005.
22. Gulley S, Sharma SK, Moran TH, Sayegh AI. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors. Peptides 26: 1617-1622, 2005.
23. Kreis ME, Zittel TT, Raybould HE, Reeve JR Jr, Grundy D. Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared with cholecystokinin-8 in rats. Neurosci Lett 230: 89-92, 1997.
24. Monnikes H, Lauer G, Bauer C, Tebbe J, Zittel TT, Arnold R. Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid. Am J Physiol Regul Integr Comp Physiol 273: R2059-R2071, 1997.
25. Moran TH, Norgren R, Crosby RJ, McHugh PR. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res 526: 95-102, 1990.
26. Moran TH, Smith GP, Hostetler AM, McHugh PR. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 415: 149-152, 1987.
27. Muller MK, Goebell H, Alfen R, Ehlers J, Jager M, Plumpe H. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat. J Nutr 118: 645-650, 1988.
28. Nagar AB, Gorelick FS. Acute pancreatitis. Curr Opin Gastroenterol 20: 439-443, 2004.
29. Nemeth PR, Zafirov DH, Wood JD. Effects of cholecystokinin, caerulein and pentagastrin on electrical behavior of myenteric neurons. Eur J Pharmacol 116: 263-269, 1985.
30. Otsuki M, Tani S, Fujii M, Nakamura T, Okabayashi Y, Koide M. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats. Am J Physiol Regul Integr Comp Physiol 265: R896-R901, 1993.
31. Patterson LM, Zheng H, Berthoud HR. Vagal afferents innervating the gastrointestinal tract and CCKA-receptor immunoreactivity. Anat Rec 266: 10-20, 2002.
32. Paxinos G, Watson C. The Rat Brain in Sterotaxic Coordinates. San Diego: Academic, 1997.
33. Raboin SJ, Gulley S, Henley SC, Chan WC, Esdaile AR, Jackson CA, Billups LH, Sayegh AI. Effect of sympathectomy and demedullation on increased myenteric and dorsal vagal complex Fos-like immunoreactivity by cholecystokinin-8. Regul Pept 134: 141-148, 2006.
34. Raboin SJ, Gulley S, Henley SC, Chan WC, Esdaile AR, Jackson CA, Sayegh AI. Adrenalectomy attenuates myenteric but not dorsal vagal complex Fos-like immunoreactivity by cholecystokinin-8. Am J Vet Res, 67, 1552-1556, 2006.
35. Raboin SJ, Gulley S, Henley SC, Chan WC, Esdaile AR, Sayegh AI. Atropine methyl nitrate increases myenteric but not dorsal vagal complex Fos-like immunoreactivity in the rat. Physiol Behav 88: 448-452, 2006.
36. Reeve JR Jr, Green GM, Chew P, Eysselein VE, Keire DA. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am J Physiol Gastrointest Liver Physiol 285: G255-G265, 2003.
37. Reeve JR Jr, Wu SV, Keire DA, Faull K, Chew P, Solomon TE, Green GM, Coskun T. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am J Physiol Gastrointest Liver Physiol 286: G395-G402, 2004.
38. Richards W, Hillsley K, Eastwood C, Grundy D. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat. J Physiol 497: 473-481, 1996.
39. Ritter RC, Brenner LA, Tamura CS. Endogenous CCK and the peripheral neural substrates of intestinal satiety. Ann NY Acad Sci 713: 255-267, 1994.
40. Rocca AS, LaGreca J, Kalitsky J, Brubaker PL. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142: 1148-1155, 2001.
41. Sayegh AI, Ritter RC. CCK-A receptor activation induces fos expression in myenteric neurons of rat small intestine. Regul Pept 88: 75-81, 2000.
42. Sayegh AI, Ritter RC. Vagus nerve participates in CCK-induced Fos expression in hindbrain but not myenteric plexus. Brain Res 878: 155-162, 2000.
43. Schutte IW, Hollestein KB, Akkermans LM, Kroese AB. Evidence for a role of cholecystokinin as neurotransmitter in the guinea-pig enteric nervous system. Neurosci Lett 236: 155-158, 1997.
44. Shapiro RE, Miselis RR. The central neural connections of the area postrema of the rat. J Comp Neurol 234: 344-364, 1985.
45. Shapiro RE, Miselis RR. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 238: 473-488, 1985.
46. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036-1037, 1981.
47. Tatemoto K, Jornvall H, Siimesmaa S, Hallden G, Mutt V. Isolation and characterization of cholecystokinin-58 (CCK-58) from porcine brain. FEBS Lett 174: 289-293, 1984.
48. Voigt JP, Wenz D, Voits M, Fink H. Does increased endogenous CCK interact with serotonin to reduce food intake in rats? Peptides 21: 1895-1901, 2000.
49. Webb T, Gulley S, Esdaile AR, Pruitt F, Sharma SK, Williams CS, Sayegh AI. Effects of cholecystokinin-receptor antagonists on Fos-like immunoreactivity stimulated by sulfated cholecystokinin-8 in neurons of the myenteric plexus and hindbrain of rats. Am J Vet Res 66: 1308-1313, 2005.
50. Webb T, Gulley S, Pruitt F, Esdaile AR, Sharma SK, Cox JE, Smith GP, Sayegh AI. Cholecystokinin-8 increases Fos-like immunoreactivity in myenteric neurons of the duodenum and jejunum more after intraperitoneal than after intravenous injection. Neurosci Lett 389: 157-162, 2005.
51. Weller A, Smith GP, Gibbs J. Endogenous cholecystokinin reduces feeding in young rats. Science 247: 1589-1591, 1990.
52. Yamamoto M, Reeve JR Jr, Keire DA, and Green GM. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Am J Physiol Gastrointest Liver Physiol 288: G866-G879, 2005.
53. Yox DP, Brenner L, Ritter RC. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 262: R554-R561, 1992.
54. Yox DP, Ritter RC. Capsaicin attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 255: R569-R574, 1988.
55. Yox DP, Stokesberry H, Ritter RC. Vagotomy attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 260: R503-R508, 1991.